Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells

Despite being a high priority for vaccine development, no vaccine is yet available for respiratory syncytial virus (RSV). A live virus vaccine is the primary type of vaccine being developed for young children. In this report, we describe our studies of infected cotton rats and primary human airway e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Binh, Chirkova, Tatiana, Boukhvalova, Marina S., Sun, He Ying, Walsh, Edward E., Anderson, Christopher S., Mariani, Thomas J., Anderson, Larry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789749/
https://www.ncbi.nlm.nih.gov/pubmed/31330970
http://dx.doi.org/10.3390/vaccines7030069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789749/
https://www.ncbi.nlm.nih.gov/pubmed/31330970
http://dx.doi.org/10.3390/vaccines7030069

Ejemplares similares